Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Allied BiotechROCO:1780 -1.76%77 Dividend Yield % is 5.61% as of Jul. 19, 2026, which is 42% above its 10-year median of 3.96. GuruFocus rates ROCO:1780 with a GF Score™ of 77/100 and a GF Value™ of NT$20.77 (Fairly Valued). The stock has 5 warning signs investors should review. Among 513 Drug Manufacturers companies, Allied Biotech ranks better than 93.57% on this metric.
As of today (2026-07-19), the Trailing Annual Dividend Yield of Allied Biotech is 5.61%.
Good Sign:
Allied Biotech Corp stock Dividend Yield % is close to 10-year high.
The historical rank and industry rank for Allied Biotech's Dividend Yield % or its related term are showing as below:
ROCO:1780'
s Dividend Yield % Range Over the Past 10 Years
Min: 1.58 Med: 3.96 Max: 5.78
Current: 5.61
During the past 13 years, the highest Dividend Yield of Allied Biotech was 5.78%. The lowest was 1.58%. And the median was 3.96%.
ROCO:1780's Dividend Yield % is ranked better than 93.57% of 513
companies
in the Drug Manufacturers industry
Industry Median: 1.92
vs ROCO:1780: 5.61
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Allied Biotech Corp is 0.74, which seems too high.
During the past 13 years, the highest Dividend Payout Ratio of Allied Biotech was 5.71. The lowest was 0.32. And the median was 0.86.
During the past 12 months, Allied Biotech's average Dividends Per Share Growth Rate was 17.60% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 26.00% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 3.10% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Allied Biotech was 35.70% per year. The lowest was -20.60% per year. And the median was 6.60% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for Allied Biotech's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:1780 vs ZTS, UTHR: Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Allied Biotech's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Allied Biotech Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Allied Biotech's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Allied Biotech's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Allied Biotech Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
TWD 1.250000
2026-06-04
2026-06-05
2026-07-03
Cash Dividend
annually
TWD:TWD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Allied Biotech's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
1.25
/
22.30
=
5.61 %
Current Share Price is NT$22.30. Allied Biotech's Dividends per Share for the trailing twelve months (TTM) ended in Today is NT$1.25.
Allied Biotech's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
1.25
/
22.30
=
5.61 %
Current Share Price is NT$22.30. Allied Biotech's Dividends per Share for the forward twelve months is calculated as NT$1.25 * 1 = NT$1.25.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Allied Biotech (ROCO:1780) has a Dividend Yield % of 5.61% as of Jul. 19, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Allied Biotech and its competitors. This is 42% above median its historical median of 3.96. Over the past decade, Allied Biotech's Dividend Yield % has ranged from 1.58 to 5.78. According to the industry distribution chart, Allied Biotech ranks #33 out of 513 companies in the Drug Manufacturers industry, placing it in the top 6.4%.
Is Allied Biotech's Dividend Yield % too high?
Allied Biotech's current Dividend Yield % of 5.61% is 42% above median its 10-year median of 3.96. Over the past 10 years, this metric has ranged from a low of 1.58 to a high of 5.78. The Drug Manufacturers industry median Dividend Yield % is 1.92. Allied Biotech's value of 5.61% is 192.2% above this industry median. Based on the distribution chart, Allied Biotech ranks #33 out of 513 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Allied Biotech has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Allied Biotech's Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Allied Biotech ranks #33 out of 513 companies for Dividend Yield %. This places Allied Biotech in the top 6% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 1.92. Allied Biotech's value of 5.61% is 192.2% above this benchmark. Historically, Allied Biotech's own Dividend Yield % has ranged from 1.58 to 5.78 over the past decade. While the company's 10-year median is 3.96 vs. the industry median of 1.92, Allied Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 1.92, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Allied Biotech's current Dividend Yield % of 5.61% is 192.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Allied Biotech and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 1.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Allied Biotech's current Dividend Yield % is 5.61%, which is 42% above median its own 10-year median of 3.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allied Biotech stock overvalued right now?
Based on GuruFocus' analysis, Allied Biotech (ROCO:1780) is currently considered Fairly Valued. The stock's GF Value™ is NT$20.77, compared to a current price of NT$22.30 — trading 7.4% above its estimated fair value. The current Dividend Yield % is 5.61%, which is 42% above median its 10-year median of 3.96 and 192.2% above the Drug Manufacturers industry median of 1.92. Allied Biotech's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Allied Biotech (ROCO:1780), the current Dividend Yield % is 5.61% as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Allied Biotech (ROCO:1780) Overvalued in 2026?
Based on GuruFocus' analysis, Allied Biotech stock appears to be overvalued.
The current stock price of NT$22.30 is trading 7.4% above its estimated GF Value™ of NT$20.77.
GuruFocus considers Allied Biotech to be Fairly Valued.
Key valuation signals for ROCO:1780:
Dividend Yield %: 5.61% (42% above median its 10-year median of 3.96)
GF Value™: NT$20.77 vs. price of NT$22.30 (7.4% above fair value)
Industry Position: 192.2% above the Drug Manufacturers median (#33 of 513)
No single metric tells the full story. See the ROCO:1780 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Allied Biotech Corp is a Taiwan based manufacturer of carotenoids. It manufactures carotenoid formulations for the food, supplement and feed industries. The company markets its products under the name Altratene.
77GF Score
Get the complete analysis for ROCO:1780
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1780 has been successfully added to your 
